Genetic determinants of HDL cholesterol (HDL-C) levels in the general population are poorly understood. We previously described plasma cholesteryl ester transfer protein (CETP) deficiency due to an intron 14 G(+l)-to-A mutation(Intl4 A) in several families with very high HDL-C levels in Japan. Subjects with HDL-C 100 mg/dl (n = 130) were screened by PCR single strand conformational polymorphism analysis of the CETP gene. Two other mutations were identified by DNA sequencing or primer-mediated restriction map modification of PCR products: a novel intron 14 splice donor site mutation caused by a T insertion at position +3 from the exonl4/intronl4 boundary (Intl4 T) and a missense mutation (Asp'2 to Gly) within exon 15 (D442G).
The Intl4 T mutation was only found in one family. However, the D442G and Intl4 A mutations were highly prevalent in subjects with HDL-C . 60 mg/dl, with combined allele frequencies of 9%, 12%, 21%, and 43% for HDL-C 60-79, 80-99, 100-119, and . 120 mg/dl, respectively. Furthermore, prevalences of the D442G and Intl4 A mutations were extremely high in a general sample of Japanese men (n = 236), with heterozygote frequencies of 7% and 2%, respectively. These two mutations accounted for about 10% of the total variance of HDL-C in this population. The phenotype in a genetic compound heterozygote (Intl4 T and Intl4 A) was similar to that of Intl4 A homozygotes (no detectable CETP and markedly increased HDL-C), indicating that the Intl4 T produces a null allele. In four D442G homozygotes, mean HDL-C levels (86±26 mg/dl) were lower than in Intl4 A homozygotes (158±35 mgldl), reflecting residual CETP activity in plasma. In 47 D442G heterozygotes, mean HDL-C levels were 91±23 mg/dl, similar to the level in D442G homozygotes, and significantly greater than mean HDL-C levels in Intl4 A heterozygotes (69±15 mg/dl). Thus, the D442G mutation acts differently to the null mutations Introduction Most prospective epidemiologic studies have shown that increased levels of HDL cholesterol (HDL-C') are an independent, negative risk factor for the development of coronary heart disease (CHD) (1) . Recent recommendations of the Adult Treatment Panel H place increased emphasis on the importance of elevated HDL, regarding HDL-C 2 60 mg/dl (1.55 mmol/liter) as a beneficial factor that negates one positive CHD risk factor (2). HDL has a unique ability to facilitate cholesterol efflux from cells, including those within atherosclerotic lesions, and subsequently to transport excess cholesterol to the liver (3) . There are several well-known environmental factors influencing HDL-C levels. Alcohol consumption, exercise, and female sex increase HDL-C levels. On the other hand, smoking, obesity, male sex, and diets high in polyunsaturated fat decrease HDL-C levels (4) . These environmental factors often influence HDL levels through the activities of lipases or lipid transfer proteins (4, 5) . Complex segregation analyses suggest no major gene determining HDL levels (6, 7); but in some recent studies, genetic factors appear to be determinants of HDL-C or apo A-I levels in the general population (8) (9) (10) (11) . However, the putative genes involved have not been determined (6) (7) (8) (9) (10) (11) . In some families, cholesteryl ester transfer protein (CETP) deficiency or increased apo A-I production rate have been identified as genetic factors causing increased HDL-C levels (12, 13) .
Plasma CETP mediates the transfer and exchange of cholesteryl ester (CE) and triglyceride (TG) between the plasma lipoproteins, and plays an important role in HDL-CE and apo A-I catabolism, and in the determination of HDL size and subclass distribution (14) . In some primary and secondary hyperlipidemias (e.g., familial hypercholesterolemia, dysbetalipoproteinemia, hypertriglyceridemia, and nephrotic syndrome) and during postprandial lipemia, accelerated CETP-mediated CE transfer results in increased CE net mass transfer from HDL to VLDL or chylomicron, probably contributing to reduced HDL-CE levels and CE enrichment of potentially atherogenic chylomicron and VLDL remnants (14) . Plasma CETP is a hydrophobic glycoprotein with 476 amino acids and 4 N-linked glycosylation sites (15) . The human CETP gene consists of 16 exons encompassing 25 kbp on chromosome 16q 13, near the lecithin:cholesterol acyltransferase and haptoglobin loci (16, 17) . Plasma CETP mRNA is highly expressed in the liver as well as peripheral tissues such as spleen, adipose, and muscle (18, 19) . Human genetic CETP deficiency was originally identified as a splicing defect in Japanese subjects with very high HDL levels (12) . The G(+ 1)-to-A transition at the intron 14 splice donor site results in a null allele: homozygotes with the mutation have no CETP in plasma and have marked elevation of HDL-C (12, 20) . Furthermore, genetic deficiency of CETP results in reduced CE contents in VLDL, intermediate density lipoprotein, and LDL, producing a potentially antiatherogenic lipoprotein profiles (20, 21) . This mutant allele frequency is high in Japanese subjects with HDL-C levels .60 mg/dl (1.55 mmollliter) (22). In the present study, we report the phenotype and prevalence of other CETP gene mutations. One is a missense mutation in the carboxy terminal of CETP, which is the same nucleotide change as the mutation found in two cases with very high HDL-C levels recently reported (23) . The other is a novel splice donor site mutation caused by a single nucleotide insertion. Our studies reveal that the missense mutation has a distinctive phenotype and suggest that its prevalence is so high that it contributes to the upward skewing of the HDL-C distribution in a sample of the general Japanese population.
Methods

Subjects
To identify CETP gene mutations in Japanese subjects with high HDL levels (i.e., familial hyperalphalipoproteinemia [FHALP]), PCR single strand conformational polymorphism (SSCP) analysis was performed in 130 consecutive unrelated individuals with increased serum HDL-C levels (:100 mg/dl) from several regions of Japan. We also screened for the known intron 14 G(+1)-to-A mutation (Intl4 A) (12, 20, 22 Four pedigrees with CETP deficiency are shown in Fig. 1 . Kindred FHALP-464 contained individuals with both the Intl4 A and intron 14 T insertion (+3) (Intl4 T) mutations as well as a compound heterozygote. This family was from Hiroshima, and all members were healthy. Kindred FHALP-528 had a compound heterozygote with both the Aspto-Gly substitution at amino acid 442 (D442G) and Intl4 A mutations. This family was from the rural area around Kanazawa. Family members were all healthy. In kindred FHALP-277, a male proband with mildly increased HDL levels was found to be heterozygous for the D442G mutation. He was found to have pulmonary sarcoidosis and vasospastic angina with a normal coronary angiogram. The diagnosis of vasospasm was established by an elevation of ST segments in leads II Ill and a VF induced by intracoronary ergonovine provocation test. He was treated with diltiazem HCl. He had small bilateral xanthelasma. His lipid profiles were serum cholesterol 230±15 mg/dl (n = 6, coefficient of variation [CV] 6%, and range 208-246 mg/dl), LDL-C 134±10 mg/dl (n = 6, CV 8%, and range 115-142 mg/dl), HDL-C 70±7 mg/dl (n = 6, CV 10%, and range 64-84 mg/dl), and triglyceride 133±59 mg/dl (n = 6, CV 45%, and range 82-227 mg/dl). His healthy mother was found to be homozygous for the D442G mutation with mildly increased HDL-C levels, 76 and 80 mg/dl, on two different occasions. His mother was from southwest of Kanazawa. Other family members were healthy. In kindred FHALP-1084, a female proband was found to be a D442G homozygote. She and her family members were all healthy, except for her sibling (a homozygote) with chronic hepatitis caused by hepatitis C virus. The proband's father, an obligate heterozygote for the mutation, died of cerebral vascular attack of unknown cause. This family was from Kochi on the Shikoku Island.
DNA analysis
Single strand conformational polymorphism ofPCR products. Genomic DNA was purified from white blood cells, and in vitro amplifications of genomic DNA were performed by PCR (20, 22) . Oligonucleotide primers used for the amplification of exon 14 or 15 were based on published sequences (15, 16) . Single-strand conformational polymorphism (SSCP) analyses of the amplified DNA were performed as described (24) , with a slight modification (25) . Briefly, 9 jil PCR products were incubated with 1 ytl of alkaline solution (0.5 M sodium hydroxide, 10 mM EDTA) at 42°C for 5 min, heat-denatured at 96°C for 3 min, and loaded on 10-20% native (non-SDS) gradient polyacrylamide gel (Pagel; Atto Corp., Tokyo, Japan). The gels were run at 100 V for 10-15 h at different conditions of 4°C and room temperature in 0.6 x TBE buffer (1 x TBE buffer; 90 mM Tris-borate, pH 8.3, 4 mM EDTA). Single-stranded conformers were visualized with a silver-staining kit (Bio-Rad Laboratories, Richmond, CA). All PCR products were confirmed to be single bands resolved on agarose gel electrophoresis before performing SSCP analyses. Direct sequencing of double-strand DNA fragments of exon 14 and 15 were performed using internal sequencing primers and T7 DNA polymerase (United State Biochemical Corp., Cleveland, OH) as described elsewhere (12) .
Primer-mediated restriction map modification for the diagnosis of point mutations. All mutagenic primers used for RFLP site-creating PCR assays were based on published sequences (15, 16) Fig. 2 ). To confirm homozygosity of the D442G mutation, a Sall site (5'-gtcgac-3')-creating PCR assay was also performed. SalI site-creating forward primer E15AA and 15IB were used to detect the normal sequence (NTCGAC) corresponding to amino acid 442 (see Fig. 2 ). For the detection of the intron 14 +3 position T insertion, the 141A foward primer and an HpaI site(5'-gttaac-3') creating reverse primer 14IB3T were used for the assay. The enzyme HpaI recognized the specific sequence (GTTAAN) in PCR products derived from the T-inserted allele, generating a 141-bp fragment instead of 166-bp (see Fig. 3 ).
Analytical measurements
Fasting plasma samples were isolated by clinical centrifuge within 30 min of venesection, and frozen at -80'C until used for the activity assay. After measurements of CETP activity of plasma, the samples were shipped to Columbia University in a dry-ice package. Plasma CETP mass was determined by radioimmunoassay using l"I-labeled mAb TP2 (20) . TP2 binding to the variant CETP of D442G was normal, because the epitope of TP2 is located between amino acids 463 and 475 (26) .
3H-labeled CE containing HDL3 were prepared as described elsewhere (19 (28, 29) . The concentrations of apo A-I, A-Il, B, C-II, C-Ill, and E were determined by immunoturbidimetry as described (ApoAuto; Daiichi Chemical, Tokyo, Japan) (30) . Intraassay and between assays CV for apolipoprotein measurements were less than 6%. Serum HDL-C was determined by a heparin-calcium chloride precipitation method (20 
Results
To identify CETP gene mutations, we screened subjects with HDL-C -100 mg/dl using SSCP analyses of PCR products. All segments of 16 exons, and their flanking intronic sequences and promoter regions (-360 bp) were analyzed. Several variant conformers were identified in the regions of exon 14 and 15. These conformers were confirmed to have point mutations by direct sequencing of the PCR products. One mutation was a single-base A-to-G transition within exon 15 that changes the codon for amino acid 442 of CETP, resulting in replacement of the acidic residue aspartic acid (Asp) by the neutral residue glycine (Gly) (D442G). Unrelated subjects with HDL-C 2 60 mg/dl (n = 312) and their family members were screened for this mutation using an MspI site-creating PCR method (Fig. 2) . Remarkably, 4 homozygotes, 49 heterozygotes, and 4 genetic compound heterozygotes with the D442G mutation were found. A Sall site-creating PCR method was used to confirm homozygosity of the mutation in subjects with the D442G mutation (Fig. 2) . Three pedigrees of subjects with CETP deficiency involving the D442G mutation are shown (Fig. 1) . Mildly to moderately increased HDL tended to segregate with the D442G mutation.
Another mutation was a novel intron 14 splice donor site mutation. This mutation was a single-nucleotide insertion of T at the +3 position of the intron 14 splice donor site (Intl4 T). In the kindred of FHALP-464, this novel splice donor site mutation was identified in two generations as shown (Figs. 1  and 3 ). A daughter with no plasma CETP mass and activity, and serum HDL-C 106 mg/dl, was found to be a genetic compound heterozygote with two different splice donor site mutations involving intron 14 (pedigree position 111-2). The the Intl4 T using the PCR-based method (Fig. 3) family members were first-degree relatives of the probands (i.e., parents, children, or siblings). Subjects with the Intl4 A mutation were similar to those described in a previous report (20) . Homozygotes for the D442G mutation had 57% lower plasma CETP mass and 27% lower CETP specific activities compared to unaffected family members. HDL-C levels in the homozygotes were moderately increased (86±26 mg/dl) compared to unaffected family members, but were not as high as in homozygotes with the Intl4 A mutation (158±35 mg/dl, P < 0.001). Thus, the D442G mutant allele was only partially defective. Compared to unaffected family members, heterozygotes for the D442G mutation had 34% lower plasma CETP levels (1.44±0.51 mg/liter) and 55% lower specific activities (both P < 0.001). The differences in CETP specific activity comparing D442G heterozygotes and homozygotes were not significant. The Int14 A heterozygotes had similar reductions in plasma CETP concentration compared to the D442G heterozygotes, but had normal CETP specific activity. In the D442G heterozygotes, decreased plasma CETP levels and sp act led to a pronounced increase in HDL-C levels (91±23 mg/dl). The HDL-C levels in the D442G heterozygotes were significantly higher than those in the Intl4 A heterozygotes (69±15 mgldl, P < 0.001). Interestingly, the HDL-C levels in the D442G heterozygotes were similar to those in the D442G homozygotes. Thus, the phenotypic effects of the D442G mutation on HDL are the same whether there are one or two mutant alleles involved, and greater than expected for one partially defective allele, suggesting that the D442G allele is genetically dominant. In compound heterozygotes with the genotype Intl4 A/ D442G, the mean HDL-C levels of 129 mg/dl were somewhat lower than those in the homozygotes for the Intl4 A mutation, but higher than in heterozygotes with the Intl4 A or D442G mutation. These results are compatible with low but detectable CETP activities in plasma of the compound heterozygote (Intl4A/D442G).
The D442G homo-and heterozygotes showed increased apo A-I levels compared to unaffected family members as shown in Table II . Apo A-II levels were also increased in the D442G heterozygotes. However, the elevation in apo A-I1 levels was less remarkable so that the mass ratio of apo A-I/A-11 in the D442G heterozygotes was increased as in homo-and heterozygotes with the Intl4 A mutation. LDL cholesterol and apo B levels were not changed in partial CETP deficiency caused by the D442G homo-or heterozygotes, in contrast to decreased LDL cholesterol and apo B found in subjects with complete CETP deficiency (Tables I and II) Fig. 4 . Remarkably, 16 heterozygotes with the D442G mutation and 4 heterozygotes with the Intl4 A mutation were detected. All of these heterozygotes had HDL-C values in the range 41-85 mg/ dl. The highest numbers of subjects with CETP gene mutations were found in the group with HDL-C 60-69 mg/dl. The highest relative frequency (56%) of heterozygous CETP deficiency was observed for HDL-C values of 70-79 mg/dl. Heterozygote frequencies with the Intl4 A and D442G mutations were 1.7% (95% CI, 0.1-3.8%) and 6.8% (95% CI, 4.1-9.9%), respectively. Thus, combined gene frequency for CETP mutant alleles was q = 0.042. The mean HDL-C levels in subjects with heterozygous CETP deficiency caused by either mutation (n = 20, 62±12 mg/dl) were significantly higher than those in subjects without CETP deficiency (n = 216, 48+ 12 mg/dl, P = 0.0001).
The number of subjects with the Intl4 A mutation was too small to permit meaningful comparisons of HDL-C levels for the two different genotypes. Multiple regression analysis was performed by stepwise forward selection, using five variables (age, alcohol consumption, cigarette smoking, body mass index, and CETP genotype). All factors, except for age, were significant predictors of serum HDL-C levels in the sample of general Japanese men (Table IV) . The adjusted R2 values derived from the four variables was 28%, and 18% after exclusion of the CETP genotype from variables. Furthermore, 10% of total phenotypic variance of HDL-C was attributable to the presence of genetic CETP deficiency in the sample of general Japanese men 
Discussion
Genetic deficiency of CETP due to the Intl4 A mutation is well established as a common cause of increased HDL in the Japanese. In the present study, two other CETP gene mutations have been characterized. One of these is a missense mutation, changing the codon of amino acid 442 from aspartate to glycine (D442G). The other is a novel splice donor site mutation due to a T insertion. Although there are distinctive differences in its phenotypic expression, like the Intl4 A and Intl4 T, the D442G mutant has potent effects on plasma HDL. The development of PCR-based assays to detect these mutations allowed population studies to be conducted. Remarkably, the D442G mutation was found to be present in 18% of subjects with HDL-C 2 60 mg/dl and in 7% of a random sample of Japanese men. The D442G mutant thus appears to be about two to four times more frequent than the common Intl4 A mutation. Although these data are based on small selected samples, genetic CETP deficiency is likely to be a major determinant of increased HDL-C levels in the general Japanese population, with at least as large an impact on HDL-C levels as well-known environmental factors. The high prevalence of two common CETP gene mutations suggests a biological advantage for CETP deficiency, which could be related to several putative beneficial effects of high HDL levels. The D442G mutation was so frequently found, both in subjects with increased HDL and in a general population sample, that it could be questioned whether this was a neutral polymorphism that would not affect CETP function or HDL levels. Apo levels are mean+SD, ranges and the numbers analyzed. NS, not significant. However, in kindreds, the mutation tended to segregate with high HDL-C levels ( Fig. 1 ) and among subjects with increased HDL-C, the frequency of the mutation tended to increase within strata of increasing HDL-C levels (Table III) . Also, subjects with the mutation had higher HDL-C values than those without the mutation in the general population sample (Fig. 4) . Also, it is mechanistically plausible that the D442G mutant should increase HDL-C levels, since the mutant caused decreased plasma CETP concentration and specific activity, with proportionate effects on HDL-C (Table I ). The D442G mutant is near a carboxy terminal region of CETP shown to be essential for function (14, 26) . Finally, expression of the mutant cDNA in transfected cells showed both impaired secretion and sp act of the mutant CETP compared to the wild-type (23) . Although the D442G mutant potently increased HDL levels, the magnitude of the effect was different in the different populations surveyed, possibly reflecting selection bias and/or the lower levels of HDL-C in an all-male population (Fig. 4) . Initially, the D442G was reported to cause a very high HDL-C level as a single mutant allele (23) . However, it is now evident that the D442G mutant typically results in moderate increases in HDL-C (Table I , Fig. 4) .
Although the D442G allele was partially defective, several aspects of its phenotypic expression suggest genetic dominance.
First, D442G heterozygotes and homozygotes had similar elevations in HDL-C. Second, the D442G heterozygotes had higher HDL-C values than the Intl4 A heterozygotes (Table I) . Thus, one allele with the D442G mutation has a larger effect on HDL-C than one null allele, even though the D442G mutant allele is not completely defective. These results indicate that the partially defective D442G allele tends to inhibit the expression of the wild-type allele, and are consistent with the dominant negative effects of the D442G cDNA in cell expression experiments (23) . Although the mechanism of genetic dominance is poorly understood, it could reflect formation of multimeric species of CETP during cellular secretion and/or involvement of multimers in the lipid transfer process. A novel intron 14 splice donor site mutation caused by a T insertion at the +3 position relative to the exon 14/intron 14 boundary (Intl4 T) was also identified in this study. Plasma CETP mass and activity were undetectable in a subject who was a genetic compound heterozygote with both Intl4 T and Intl4 A mutations involving the same intron 14 splice donor. Therefore, the +3 position T insertion yields a null allele with no CETP produced ( Fig. 1 kindred FHALP-464) . In addition to the invariant GT dinucleotide located in the first two positions of a splice donor site, mutations at the +3 position also have been shown to cause defective alleles in several genetic disorders (34) . Abnormal Fig. 4 ). Although the Intl4 A mutation is a common cause of hyperalphalipoproteinemia (20, 22), considered alone this mutation would not be sufficiently prevalent to influence the distribution of HDL-C levels in the general Japanese population. Unexpectedly, the frequency of the D442G mutation was found to be considerably higher than that of the Intl4 A mutation (Table III, Fig. 4) . Thus, the present study has established for the first time that genetic CETP deficiency, mainly due to the D442G mutant and to a lesser extent to the Intl4 A mutant, is sufficiently common to influence HDL-C levels in the general Japanese population. The high prevalence of two different CETP mutations could suggest a biological advantage of CETP deficiency, related to putative beneficial effects of increased HDL levels. HDL may have several different beneficial biological activities. As an antiatherogenic agent, HDL or its major protein (i.e., apo A-I) may facilitate cholesterol efflux from cells in atherosclerotic plaque (3, 4) . HDL also promotes prostacyclin secretion and stabilization (35) and acts as a major carrier of lipid hydroperoxides, leading to less retention of oxidized lipids in LDL, consequently reducing its atherogenic potential (36) . (14) . Although lower CETP levels in plasma could reduce atherogenic potential through decreasing CE contents in VLDL or chylomicron remnants as well as increasing HDL, it is not established whether decreased CETP levels are antiatherogenic in human. Population studies with a larger number of individuals are required to compare prevalences of CHD, cerebrovascular disease, and other causes of morbidity and mortality in families with CETP deficiency with those in a control population.
The distribution of HDL-C levels in other ethnic groups (44) are similar to those in the Japanese (22), consistently showing skewness towards higher levels (Fig. 4) . Furthermore, subjects with very high HDL-C levels are not rare in the Japanese (22) and other ethnic groups (45). However, genetic factors determining HDL-C levels in the general population have been poorly understood (6) (7) (8) (9) (10) (11) . In addition to genetic CETP deficiency, an apo C-Ill variant (46), hepatic lipase deficiency (47), a putative plasma CETP inhibitor (48) , and increased apo A-I production rate (13) are candidate genetic causes of increased HDL-C levels. However, except for genetic CETP deficiency, the prevalence of these defects is unknown. It has been suggested that rare recessive genes probably do not explain a significant fraction of the phenotypic variation in HDL levels in the population (6, 7) . Genetic CETP deficiency in other ethnic groups has not been documented. However, it is likely that more CETP mutants will be discovered in subjects with increased HDL both in the Japanese and other populations, because a variety of different molecular defects causing CETP deficiency have been reported; e.g., splicing defects, missense mutation, and nonsense mutation (12, 23, 49) . It is interesting to note that the independent, strong, inverse relation between HDL-C levels and incidence of CHD was initially established in men of Japanese descent living in Hawaii (50) and subsequently confirmed in most other ethnic groups (1). The incidence of CHD death in Japan is relatively low compared with those in other countries (51) . Since the frequency of heterozygous CETP deficiency is shown to be as high as 9% in Japan, CETP deficiency could have a considerable impact on HDL-C levels in the population. It is likely that CETP deficiency is a major genetic cause of high HDL-C levels in the general Japanese population. Furthermore, it is possible that genetic CETP deficiency itself represents a negative CHD risk factor, contributing to a relatively low incidence of CHD in Japan.
